Find Grants for Higher Education

Find out if you qualify for verified grants for Higher Education. Discover your eligibility and key funding details for Higher Education from major foundations and government agencies.

$ 100 Trillion
Total Dollars Available

Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)

Deadline: September 7, 2026


Opportunity Number: PAR-25-037

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242

Enhancing Reuse of NHGRI Data Assets (R03 Clinical Trial Not Allowed)

Deadline: February 15, 2026


Opportunity Number: RFA-HG-25-005

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: February 15, 2026

Status: Posted

CFDA Numbers: 93.172

Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)

Deadline: September 7, 2027


Opportunity Number: PAR-25-228

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.879, 93.172

Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

Deadline: September 7, 2027


Opportunity Number: PAR-25-229

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.172, 93.879

Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)

Deadline: May 7, 2026


Opportunity Number: PAR-25-176

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.351

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

Deadline: January 7, 2027


Opportunity Number: PAR-25-069

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.393

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2027


Opportunity Number: PAR-25-070

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.393

NCMRR Early Career Research Award (R03 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-124

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.865

NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)

Deadline: January 7, 2028


Opportunity Number: PA-25-126

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.865

NICHD Small Research Grant Program (R03 Clinical Trial Required)

Deadline: January 7, 2028


Opportunity Number: PA-25-125

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.865

NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)

Deadline: November 12, 2027


Opportunity Number: PAR-25-204

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: November 12, 2027

Status: Posted

CFDA Numbers: 93.279

NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)

Deadline: May 7, 2026


Opportunity Number: PAR-25-164

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.121

NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-105

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.121

NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)

Deadline: May 7, 2026


Opportunity Number: PAR-25-166

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.121

Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PAR-25-065

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242, 93.866

Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PAR-25-064

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.866, 93.242

Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PAR-25-039

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242

Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PAR-25-040

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Deadline: September 7, 2026


Opportunity Number: PAR-25-095

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.121, 93.866, 93.393, 93.172

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Deadline: September 7, 2026


Opportunity Number: PAR-25-096

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.121, 93.866, 93.172, 93.393

Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)

Deadline: March 16, 2026


Opportunity Number: PA-25-246

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: March 16, 2026

Status: Posted

CFDA Numbers: 93.866

Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PAR-25-067

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242

Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PAR-25-066

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)

Deadline: May 7, 2026


Opportunity Number: PAR-25-110

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.855, 93.279, 93.313, 93.242, 93.865

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)

Deadline: May 7, 2026


Opportunity Number: PAR-25-111

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.865, 93.855, 93.279, 93.313

×

Request Grant Writing Assistance from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.